跳至主要内容
临床试验/NCT04354454
NCT04354454已完成不适用

Step Into Support for Endurance and Strength (SISTERS)

Dana-Farber Cancer Institute6 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2021年1月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
21
试验地点
6
主要终点
Burden Rate

研究概览

简要总结

The Step into Support for Endurance and Strength (SISTERS) research study is evaluating whether a mobile health game designed to increase physical activity is feasible and acceptable in patients with gynecologic cancers.

-SISTERS is testing a mobile health intervention can help increase physical activity. Participants will be randomized to receive either 1) a Fitbit or 2) a Fitbit + a game + help from a friend or family member whom you chose will help the participant reach their goals. (i.e. a Teammate).

详细描述

This study is a two-arm randomized controlled pilot study designed to test the feasibility and acceptability of using a wearable accelerometer (Fitbit) vs. a wearable accelerometer (FItbit) + a game designed to help participants increase physical activity + social support improves participants' average daily step counts.

Eligible Participants will be randomly assigned into 1 of 2 groups

  1. Fitbit (wearable accelerometer) or
  2. Fitbit (wearable accelerometer) + game + help from a self-selected teammate

The study interventions involved in this research are:

  • Surveys/Interviews
  • Fitbits (also known as a wearable accelerometers or fitness trackers)
  • Way to Health Platform
  • Help from a Teammate (i.e. a friend or family member that participants choose to help them reach their goals)

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patients ≥18 years of age with a gynecologic cancer (ovarian, fallopian tube, primary peritoneal carcinoma, uterine, or cervical) who have completed cancer treatment ≥ 6 weeks prior.
  • Own a smartphone (Android or iOS).
  • Can read and provide informed consent in English.
  • Do not have cognitive, visual, or orthopedic impairments that preclude participation, as evaluated by the research staff or oncology provider.
  • Insufficiently active, as indicated by a score of <14 on the Leisure Score Index of Godin Leisure-Time Exercise Questionnaire (LSI).
  • No future chemotherapy planned (except maintenance treatments; e.g. PARP inhibitors or endocrine therapy)

排除标准

  • Patients already participating in a mobile health intervention.
  • Patients who do not own a smartphone or computer to transmit data from the wearable tracker.
  • Self-reported inability to walk 2 blocks (at any pace).
  • Patients who are unable to identify a social support partner (i.e. family member, friend, or partner) to participate in the study (if selected for the intervention arm).
  • The following special populations will be excluded from this research:
  • Adults unable to consent
  • Individuals who are not yet adults (infants, children, teenagers)
  • Pregnant women
  • Prisoners

结局指标

主要结局

Burden Rate

时间窗: 3 months

Acceptability will be defined as: ≤20% of participants reporting high study burden and ≤10% study withdrawal.

Rate of Activity

时间窗: 3 months

Perceived effectiveness will be defined as ≥70% of participants indicate that study participation motivated them to increase their activity levels.

Rate of Enrollment

时间窗: 3 months

Feasibility will be demonstrated if ≥50% eligible participants enroll

Rate of Completion

时间窗: 3 months

Feasibility will be demonstrated if ≥75% of eligible participants complete the post-baseline outcome assessments.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alexi A. Wright, MD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (6)

Loading locations...

相似试验